@article{011568bf696b4f58ae2eff22f9447f5c,
title = "Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in Canada",
author = "Ko, {Dennis T.} and Tareq Ahmed and Austin, {Peter C.} and Cantor, {Warren J.} and Paul Dorian and Michael Goldfarb and Yanyan Gong and Graham, {Michelle M.} and Jing Gu and Hawkins, {Nathaniel M.} and Thao Huynh and Humphries, {Karin H.} and Maria Koh and Yoan Lamarche and Lambert, {Laurie J.} and Lawler, {Patrick R.} and L{\'e}gar{\'e}, {Jean Francois} and Ly, {Hung Q.} and Feng Qiu and Quraishi, {Ata ur Rehman} and So, {Derek Y.} and Welsh, {Robert C.} and Wijeysundera, {Harindra C.} and Graham Wong and Yan, {Andrew T.} and Yana Gurevich",
note = "Funding Information: This study was supported by the ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES, or the MOHLTC, is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. The analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI. This study was undertaken with involvement by the Canadian Cardiovascular Society Quality Reporting Steering Committee and is endorsed by the Canadian Cardiovascular Society. Funding Information: This study was supported by the ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES, or the MOHLTC, is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. The analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI. This study was undertaken with involvement by the Canadian Cardiovascular Society Quality Reporting Steering Committee and is endorsed by the Canadian Cardiovascular Society. This study was funded by a Foundation grant (FDN 154333) from the Canadian Institutes of Health Research (CIHR) awarded to Dr Ko. Dr Ko is supported by the Jack Tu Chair in Cardiovascular Outcomes Research. Dr Austin is supported by a Mid-Career Award from the Heart and Stroke Foundation of Canada (HSFC). Dr Lee is supported by the Ted Rogers Chair in Heart Function Outcomes. Dr Wijeysundera is supported by a Clinician Scientist Award from HSFC. Dr Patrick Lawler has received consulting fees from Novartis. Dr Welsh has received research grants from Astra Zeneca, Bayer, Boehringer Ingelheim, and Pfizer, and personal fees from Bayer and Quidel. The other authors have no conflicts of interest to disclose. Funding Information: This study was funded by a Foundation grant (FDN 154333) from the Canadian Institutes of Health Research (CIHR) awarded to Dr Ko. Dr Ko is supported by the Jack Tu Chair in Cardiovascular Outcomes Research. Dr Austin is supported by a Mid-Career Award from the Heart and Stroke Foundation of Canada (HSFC) . Dr Lee is supported by the Ted Rogers Chair in Heart Function Outcomes . Dr Wijeysundera is supported by a Clinician Scientist Award from HSFC. Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2021",
month = aug,
doi = "10.1016/j.cjco.2021.04.012",
language = "English",
volume = "3",
pages = "1051--1059",
journal = "CJC Open",
issn = "2589-790X",
publisher = "Elsevier Inc.",
number = "8",
}